Last $6.72 USD
Change Today +0.06 / 0.90%
Volume 29.0K
As of 5:20 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

neothetics inc (NEOT) Snapshot

Open
$6.75
Previous Close
$6.66
Day High
$6.82
Day Low
$6.58
52 Week High
11/20/14 - $14.10
52 Week Low
12/23/14 - $6.11
Market Cap
91.5M
Average Volume 10 Days
28.6K
EPS TTM
$-4.81
Shares Outstanding
13.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NEOTHETICS INC (NEOT)

Related News

No related news articles were found.

neothetics inc (NEOT) Related Businessweek News

No Related Businessweek News Found

neothetics inc (NEOT) Details

Neothetics, Inc., a clinical-stage specialty pharmaceutical company, engages in developing therapeutics for the aesthetic market. Its lead product candidate includes LIPO-202, an injectable formulation of salmeterol xinafoate that has completed Phase II development for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. The company is also developing LIPO-102 for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye. The company was formerly known as Lipothera, Inc. and changed its name to Neothetics, Inc. in August 2014. Neothetics, Inc. was founded in 2007 and is headquartered in San Diego, California.

9 Employees
Last Reported Date: 11/20/14
Founded in 2007

neothetics inc (NEOT) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $467.0K
Chief Financial Officer
Total Annual Compensation: $293.6K
Chief Scientific Officer
Total Annual Compensation: $370.3K
Compensation as of Fiscal Year 2013.

neothetics inc (NEOT) Key Developments

Neothetics, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 01:30 PM

Neothetics, Inc. Presents at Cowen and Company 35th Annual Healthcare Conference, Mar-02-2015 01:30 PM. Venue: The Boston Marriott Copley Place, Boston, Massachusetts, United States. Speakers: George W. Mahaffey, Chairman, Chief Executive Officer and President.

Neothetics, Inc. Announces Creation of Corporate Advisory Board

Neothetics, Inc. announced the creation of a corporate advisory board composed of plastic surgeons, dermatologists and other physicians. The advisory board will provide expertise regarding research, product development, regulatory affairs and product positioning as the company advances the development of its lead compound, LIPO-202, for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. Members of the corporate advisory board include: Glynis Ablon, M.D., F.A.A.D.; Doris Day, M.D., F.A.A.D., M.A.; Julius Few, M.D., F.A.C.S.; Michael H. Gold, M.D.; David J. Goldberg, M.D., J.D.; Mark L. Jewell, M.D., P.C.; Michael Kane, M.D.; Thomas F. Kent, M.D.; Z. Paul Lorenc, M.D., F.A.C.S.; Mark S. Nestor, M.D., Ph.D.; Marina I. Peredo, M.D., F.A.A.D.; W. Philip Werschler, M.D., F.A.A.D., F.A.A.C.S.; V. Leroy Young, M.D., F.A.C.S.

Neothetics, Inc.(NasdaqGM:NEOT) added to NASDAQ Composite Index

Neothetics, Inc. will be added to the NASDAQ Composite Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEOT:US $6.72 USD +0.06

NEOT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEOT.
View Industry Companies
 

Industry Analysis

NEOT

Industry Average

Valuation NEOT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOTHETICS INC, please visit www.lithera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.